Abstract
We hypothesized that injection of anti-basal antibodies from patients with Sydenham’s chorea into rats’ striatum will induce behavioral and histological changes. Antibodies from eight Sydenham’s chorea patients and eight age-matched controls were injected into the left caudate of 16 rats. Apomorphine- and amphetamine-induced rotations were performed on days 10 and 17, respectively, followed by immunohistochemical studies. Antibodies from patients with Sydenham’s chorea, but not controls, bound to a ∼50-kDa molecule in the striatum extract; immunohistology staining demonstrated specific binding to cellular component(s) in rats’ striatum. Contrary to our hypothesis, we could not detect in the rats injected with Sydenham’s chorea antibodies changes in rotational behavior or immunohistochemistry staining for dopaminergic or GABAergic markers. Injection of small quantities of anti-neuronal antibodies present in patients with Sydenham’s chorea into rat striatum is insufficient to alter motor behavior or cause detectable cellular changes.
References
Aron AM (2005) Sydenham’s chorea: positron emission tomographic (PET) scan studies. J Child Neurol 20:832–833
Asbahr FR, Ramos RT, Costa AN, Sassi RB (2005) Obsessive-compulsive symptoms in adults with history of rheumatic fever, Sydenham’s chorea and type I diabetes mellitus: preliminary results. Acta Psychiatr Scand 111:159–161
Ben-Pazi H, Livne A, Shapira Y, Dale RC (2003) Parkinsonian features after streptococcal pharyngitis. J Pediatr 143:267–269
Breakefield XO, Blood AJ, Li Y, Hallett M, Hanson PI, Standaert DG (2008) The pathophysiological basis of dystonias. Nat Rev Neurosci 9:222–234
Cardoso F, Eduardo C, Silva AP, Mota CC (1997) Chorea in fifty consecutive patients with rheumatic fever. Mov Disord 12:701–703
Cardoso F, Vargas AP, Oliveira LD, Guerra AA, Amaral SV (1999) Persistent Sydenham’s chorea. Mov Disord 14:805–807
Church AJ, Cardoso F, Dale RC, Lees AJ, Thompson EJ, Giovannoni G (2002) Anti-basal ganglia antibodies in acute and persistent Sydenham’s chorea. Neurology 59:227–231
Church AJ, Dale RC, Giovannoni G (2004) Anti-basal ganglia antibodies: a possible diagnostic utility in idiopathic movement disorders? Arch Dis Child 89:611–614
Dale RC, Heyman I, Surtees RA, Church AJ, Giovannoni G, Goodman R et al (2004) Dyskinesias and associated psychiatric disorders following streptococcal infections. Arch Dis Child 89:604–610
Emery ES, Vieco PT (1997) Sydenham chorea: magnetic resonance imaging reveals permanent basal ganglia injury. Neurology 48:531–533
Garvey MA, Snider LA, Leitman SF, Werden R, Swedo SE (2005) Treatment of Sydenham’s chorea with intravenous immunoglobulin, plasma exchange, or prednisone. J Child Neurol 20:424–429
Giedd JN, Rapoport JL, Kruesi MJ, Parker C, Schapiro MB, Allen AJ et al (1995) Sydenham’s chorea: magnetic resonance imaging of the basal ganglia. Neurology 45:2199–2202
Gilgun-Sherki Y, Melamed E, Ziv I, Offen D (2003) Riluzole, an inhibitor of glutamatergic transmission, suppresses levodopa-induced rotations in 6-hydroxydopamine-lesioned rats. Pharmacol Toxicol 93:54–56
Haber SN (2003) The primate basal ganglia: parallel and integrative networks. J Chem Neuroanat 26:317–330
Hallett JJ, Harling-Berg CJ, Knopf PM, Stopa EG, Kiessling LS (2000) Anti-striatal antibodies in Tourette syndrome cause neuronal dysfunction. J Neuroimmunol 111:195–202
Jordan LC, Singer HS (2003) Sydenham chorea in children. Curr Treat Options Neurol 5:283–290
Kells AP, Henry RA, Connor B (2008) AAV-BDNF mediated attenuation of quinolinic acid-induced neuropathology and motor function impairment. Gene Ther 15:966–977
Kirvan CA, Swedo SE, Heuser JS, Cunningham MW (2003) Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat Med 9:914–920
Kirvan CA, Cox CJ, Swedo SE, Cunningham MW (2007) Tubulin is a neuronal target of autoantibodies in Sydenham’s chorea. J Immunol 178:7412–7421
Loiselle CR, Lee O, Moran TH, Singer HS (2004) Striatal microinfusion of Tourette syndrome and PANDAS sera: failure to induce behavioral changes. Mov Disord 19:390–396
Mitchell IJ, Jackson A, Sambrook MA, Crossman AR (1989) The role of the subthalamic nucleus in experimental chorea. Evidence from 2-deoxyglucose metabolic mapping and horseradish peroxidase tracing studies. Brain 112(Pt 6):1533–1548
Moreau C, Devos D, Delmaire C, Gervais C, Defebvre L, Destee A (2005) Progressive MRI abnormalities in late recurrence of Sydenham’s chorea. J Neurol 252:1341–1344
Naidu S, Narasimhachari N (1980) Sydenham’s chorea: a possible presynaptic dopaminergic dysfunction initially. Ann Neurol 8:445–447
Nausieda PA, Grossman BJ, Koller WC, Weiner WJ, Klawans HL (1980) Sydenham chorea: an update. Neurology 30:331–334
Paz JA, Silva CA, Marques-Dias MJ (2006) Randomized double-blind study with prednisone in Sydenham’s chorea. Pediatr Neurol 34:264–269
Rakhilin SV, Olson PA, Nishi A, Starkova NN, Fienberg AA, Nairn AC et al (2004) A network of control mediated by regulator of calcium/calmodulin-dependent signaling. Science 306:698–701
Schallert T, Fleming SM, Leasure JL, Tillerson JL, Bland ST (2000) CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology 39:777–787
Singer HS, Loiselle CR, Lee O, Garvey MA, Grus FH (2003) Anti-basal ganglia antibody abnormalities in Sydenham chorea. J Neuroimmunol 136:154–161
Sulzer D, Chen TK, Lau YY, Kristensen H, Rayport S, Ewing A (1995) Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport. J Neurosci 15:4102–4108
Taylor JR, Morshed SA, Parveen S, Mercadante MT, Scahill L, Peterson BS et al (2002) An animal model of Tourette’s syndrome. Am J Psychiatry 159:657–660
Teixeira AL, Cardoso F, Maia DP, Cunningham MC (2003) Sydenham’s chorea may be a risk factor for drug induced parkinsonism. J Neurol Neurosurg Psychiatry 74:1350–1351
Teixeira AL Jr, Guimaraes MM, Romano-Silva MA, Cardoso F (2005) Serum from Sydenham’s chorea patients modifies intracellular calcium levels in PC12 cells by a complement-independent mechanism. Mov Disord 20:843–845
Tumas V, Caldas CT, Santos AC, Nobre A, Fernandes RM (2007) Sydenham’s chorea: clinical observations from a Brazilian movement disorder clinic. Parkinsonism Relat Disord 13:276–283
Walker KG, Lawrenson J, Wilmshurst JM (2005) Neuropsychiatric movement disorders following streptococcal infection. Dev Med Child Neurol 47:771–775
Walker AR, Tani LY, Thompson JA, Firth SD, Veasy LG, Bale JF Jr (2007) Rheumatic chorea: relationship to systemic manifestations and response to corticosteroids. J Pediatr 151:679–683
Acknowledgments
We thank Yael Barhum, Maia Ratner-Horvitz, Hamutal Gur, Noam Shteren, Ruth Fishel, Ofer Mendelbaum, and Zami Ben-Sasson for laboratory assistance. This study was funded in part by the Mirski Fund.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ben-Pazi, H., Sadan, O. & Offen, D. Striatal Microinjection of Sydenham Chorea Antibodies: Using a Rat Model to Examine the Dopamine Hypothesis. J Mol Neurosci 46, 162–166 (2012). https://doi.org/10.1007/s12031-011-9559-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-011-9559-6